Back to Search
YANA PIKMAN, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1669659116Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
242666(MA)
Research & Publications (8)
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
PMID 16834459·PLoS Med·2006
7-preclinical
Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
PMID 17906464·Curr Opin Oncol·2007
6-review
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.
PMID 19287095·J Clin Invest·2009
7-preclinical
Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray.
PMID 18723266·Exp Hematol·2008
8-other
The CDK-activating kinase (CAK) Csk1 is required for normal levels of homologous recombination and resistance to DNA damage in fission yeast.
PMID 18231579·PLoS One·2008
8-other
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.
PMID 16868251·Blood·2006
8-other
Peters anomaly in association with multiple midline anomalies and a familial chromosome 4 inversion.
PMID 16754208·Ophthalmic Genet·2006
5-case
Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation.
PMID 16365288·Proc Natl Acad Sci U S A·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 632-3701
Quick Facts
- NPI
- 1669659116
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile